Victor Ona

5.0k citations

22 papers · 4.1k indexed · 4 hit papers · h-index 14

Impact in

Neurology top 0.5%
- Neuroinflammation and Neurodegeneration Mechanisms
- Amyotrophic Lateral Sclerosis Research
- Parkinson's Disease Mechanisms and Treatments
Cellular and Molecular Neuroscience top 1%
- Genetic Neurodegenerative Diseases
- Neuroscience and Neuropharmacology Research

Papers in

Neurology 6
- Amyotrophic Lateral Sclerosis Research 2
Cellular and Molecular Neuroscience 6
- Genetic Neurodegenerative Diseases 6
- Neuroscience and Neuropharmacology Research 3

Co-authors: Robert M. Friedlander Mingwei Li Robert J. Ferrante Shan Zhu Serge Przedborski Philip E. Stieg J. Jang‐Ho L. John Andrews
Journals: Neurosurgery (3 papers)Journal of Neurochemistry (3 papers)Neuroscience (2 papers)Nature (2 papers)Nature Medicine (1 paper)
Partner nations: United States Germany United Kingdom

In The Last Decade

Victor Ona

21 papers receiving 4.0k citations

Hit Papers

align trajectories log scale

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice 2002 · 877 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2002 Nature
2000 Nature Medicine
2000 Science
1999 Nature

Peers

Countries citing papers authored by Victor Ona

Since Specialization

Citations

This map shows the geographic impact of Victor Ona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victor Ona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victor Ona more than expected).

Fields of papers citing papers by Victor Ona

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victor Ona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victor Ona. The network helps show where Victor Ona may publish in the future.

Co-authors

The 25 scholars most cited alongside Victor Ona, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Victor Ona Line = papers co-authored together Victor Ona links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Safety, Tolerability, and Pharmacodynamics of the ADAMTS‐5 Nanobody M6495: Two Phase 1, Single‐Center, Double‐Blind, Randomized, Placebo‐Controlled Studies in Healthy Subjects and Patients With Osteoarthritis ACR Open Rheumatology ·Asger Reinstrup Bihlet, Xiaotao, Kosalaram Goteti, Jesper Sonne, C. Ladel, M.A. Karsdal, Victor Ona, Flavie Moreau, นพภาพร พานิช, Anne‐Christine Bay‐Jensen, Hans Guehring	2024	9
2	Effects of zuranolone on next-day simulated driving in healthy adults Psychopharmacology ·Joi Dunbar, Rishi Kumar Bharti Irfan Ahmad, Rakesh K. Jain, Mélanie Perrier, Indrani Nandy, Victor Ona, 小山正三朗, Yikwon Kim, Gary G. Kay	2024	1
3	Cognitive effects, pharmacokinetics, and safety of zuranolone administered alone or with alprazolam or ethanol in healthy adults in a phase 1 trial Journal of Psychopharmacology ·Joi Dunbar, David P. Walling, 崔一梅, Rakesh K. Jain, Andrew H. Czysz, Indrani Nandy, Victor Ona, 小山正三朗, Yikwon Kim, Paul Maruff	2024	1
4	Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study Annals of the Rheumatic Diseases ·F. Eckstein, Marc C. Hochberg, Hans Guehring, Flavie Moreau, Victor Ona, Asger Reinstrup Bihlet, I. Byrjalsen, J.R. Andersen, Y.Z.B. Li, Xiao xue Zhang, C. Ladel, M. Michaelis, Philip G. Conaghan	2021	73
5	Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll‐like receptors 7 and 8 Pharmacology Research & Perspectives ·Andreas Port, О. В. Ковалюк, YU Zhibin, Ronald N. Beshara, Claudia S. Vetter, Elizabeth K. Hussey, Mark CF Tsui, Victor Ona, Danielle Cram, Alfons M. P. Knoers, JC Rudikoff, Kosalaram Goteti	2021	36
6	Safety and clinical activity of atacicept in the long-term extension of the phase 2b ADDRESS II study in systemic lupus erythematosus Lara D. Veeken ·Daniel J. Wallace, David Isenberg, Eric F. Morand, Fitzgerald Jj, Amy Kao, Aida Aydemir, Sharifa NorulAkmar Syed Zamri, Victor Ona, Cynthia Aranow, Joan T. Merrill	2021	21
7	Long-term efficacy and safety of intra-articular sprifermin in patients with knee osteoarthritis: results from the 5-year forward study Osteoarthritis and Cartilage ·F. Eckstein, Marc C. Hochberg, Grant C. Coomer, Hans Guehring, Flavie Moreau, Victor Ona, Asger Reinstrup Bihlet, I. Byrjalsen, J.R. Andersen, Y.Z.B. Li, Xiao xue Zhang, C. Ladel, M. Michaelis, Philip G. Conaghan	2020	3
8	210 Integrated safety profile of atacicept from all clinical studies to date Abstracts ·Caroline Gordon, Roberto Bassi, Peter Chang, Amy Kao, David Jayne, David Wofsy, Victor Ona, Patricia Fleuranceau-Morel	2019	0
9	Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation American Journal of Respiratory and Critical Care Medicine ·Gerald Horan, Susan Wood, Victor Ona, Dan Jun Li, Matvey Lukashev, Paul H. Weinreb, Kenneth J. Simon, Kyungmin Hahm, Norm Allaire, Ana Mercedes Colón, Jaya Goyal, Carol Feghali‐Bostwick, Eric L. Matteson, Carl O’Hara, Robert Lafyatis, Gerald S. Davis, Xiaozhu Huang, Dean Sheppard, Shelia M. Violette	2007	331
10	Sequential activation of individual caspases, and of alterations in Bcl‐2 proapoptotic signals in a mouse model of Huntington's disease Journal of Neurochemistry ·Yu Zhang, Victor Ona, Mingwei Li, S.O. DeLong, Michel Dubois‐Dauphin, Serge Przedborski, Robert J. Ferrante, Robert M. Friedlander	2003	58
11	Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice Nature ·Shan Zhu, Irina G. Stavrovskaya, S.O. DeLong, Betty Y.S. Kim, Victor Ona, Mingwei Li, Satinder S. Sarang, Allen S. Liu, Dean M. Hartley, Du Chu Wu, Steven R. Gullans, Robert J. Ferrante, Serge Przedborski, Bruce S. Kristal, Robert M. Friedlander Hit paper breakdown →	2002	877
12	Minocycline Reduces Traumatic Brain Injury-mediated Caspase-1 Activation, Tissue Damage, and Neurological Dysfunction Neurosurgery ·A.V. Samant X. L.Wei P. Pirouz, Victor Ona, Mingwei Li, Robert M. Friedlander	2001	151
13	Minocycline Reduces Traumatic Brain Injury-mediated Caspase-1 Activation, Tissue Damage, and Neurological Dysfunction Neurosurgery ·A.V. Samant X. L.Wei P. Pirouz, Victor Ona, Mingwei Li, Robert M. Friedlander	2001	291
14	Functional role and therapeutic implications of neuronal caspase-1 and -3 in a mouse model of traumatic spinal cord injury Neuroscience ·Abla Bouguerne, Victor Ona, M. Chen, Marcus Kaul, Lalitha Tenneti, X. Zhang, Philip E. Stieg, Stuart A. Lipton, Robert M. Friedlander	2000	160
15	Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease Nature Medicine ·Minghua Chen, Victor Ona, Mingwei Li, Robert J. Ferrante, Klaus Fink, Shan Zhu, Jie Bian, Lei Guo, Laurie Farrell, Mirza Muhammad Maroof Baig,Muhammad Faisal Iqbal,Beenish Mushtaque,Noor Ul Huda Noor Ul Huda,Iqra Noor,Anas Jahangir,Muhammad Nouman Khalid,Rameesha Ashraf,Haneeza Murtaza,Ali Iqbal,Nahl Jameel, Wendy Hobbs, Jean‐Paul Vonsattel, J. Jang‐Ho, Robert M. Friedlander Hit paper breakdown →	2000	869
16	Malonate and 3‐Nitropropionic Acid Neurotoxicity Are Reduced in Transgenic Mice Expressing a Caspase‐1 Dominant‐Negative Mutant Journal of Neurochemistry ·Ole A. Andreassen, Robert J. Ferrante, Duncan B. Hughes, Péter Klivènyi, Alpaslan Dedeoglu, Victor Ona, Robert M. Friedlander, M. Flint Beal	2000	36
17	Functional Role of Caspase-1 and Caspase-3 in an ALS Transgenic Mouse Model Science ·Mingwei Li, Victor Ona, Christelle Guégan, Minghua Chen, Vernice Jackson‐Lewis, L. John Andrews, Adam J. Olszewski, Philip E. Stieg, Pratima Khandelwal, Serge Przedborski, Robert M. Friedlander Hit paper breakdown →	2000	585
18	Reduction of post-traumatic brain injury and free radical production by inhibition of the caspase-1 cascade Neuroscience ·Klaus Fink, L. John Andrews, William E. Butler, Victor Ona, Abla Bouguerne, Mikhail Bogdanov, Matthias Endres, Sohail Q. Khan, G. Ibadoglu, Philip E. Stieg, M. Flint Beal, Michael A. Moskowitz, Junying Yuan, Robert M. Friedlander	1999	79
19	Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease Nature ·Victor Ona, Mingwei Li, Jean Paul Vonsattel, L. John Andrews, Sohail Q. Khan, N.A. Sklyarova, N Petrova -Phd, Anil Menon, Xiao‐Jiang Li, Philip E. Stieg, Junying Yuan, John B. Penney, Sumitra Woodhull, J. Jang‐Ho, Robert M. Friedlander Hit paper breakdown →	1999	504
20	Intraventricular Administration of a Caspase Inhibitor Delays Disease Progression and Mortality in a Mouse Model of Huntington's Disease Neurosurgery ·Robert M. Friedlander, Victor Ona, Mingwei Li, Jean Paul Vonsattel, L. John Andrews, Sohail Q. Khan, N.A. Sklyarova, N Petrova -Phd, Anil Menon, Philip E. Stieg, Junying Yuan, John B. Penney, Anne B. Young, J. Jang‐Ho	1999	2

About Victor Ona

Victor Ona is a scholar working on Neurology, Cellular and Molecular Neuroscience, Rehabilitation, Physical Therapy, Sports Therapy and Rehabilitation and Rheumatology, having authored 22 papers that have together received 4.1k indexed citations. Recurring topics across this work include Mitochondrial Function and Pathology (6 papers), Genetic Neurodegenerative Diseases (6 papers), Neuroscience and Neuropharmacology Research (3 papers), Cell death mechanisms and regulation (3 papers), Knee injuries and reconstruction techniques (2 papers), Osteoarthritis Treatment and Mechanisms (2 papers), Exercise and Physiological Responses (2 papers) and Amyotrophic Lateral Sclerosis Research (2 papers). The work is most often cited by research in Neurology (979 citations), Neurology (1.3k citations), Cellular and Molecular Neuroscience (1.4k citations), Developmental Neuroscience (213 citations) and Biological Psychiatry (111 citations). Victor Ona has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Robert M. Friedlander, Mingwei Li, Mingwei Li, Robert J. Ferrante, Shan Zhu, Serge Przedborski, Philip E. Stieg, J. Jang‐Ho, L. John Andrews and Klaus Fink. Their work appears in journals such as Neurosurgery, Journal of Neurochemistry, Neuroscience, Nature and Nature Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact